Health ❯ Medicine

Cardiology

Heart Disease Heart Conditions Heart Failure Regenerative Medicine Hypertension Medical Professionals Cardiomyopathy Cholesterol Heart Surgery Cardiovascular Disease

Edoxaban Shows No Net Benefit for Atrial Fibrillation Patients After Intracranial Haemorrhage

Investigators recommend individualized care after ENRICH‑AF, citing excess haemorrhagic stroke plus major bleeding with edoxaban

Scientists Find Small Molecules That Directly Inhibit β‑Arrestins

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

Roberto Kalil Filho Is Installed in Academia Nacional de Medicina with President Lula Present

Roberto Kalil Wins Seat No. 1 at Brazil's National Academy of Medicine

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

Digital Twin Hearts Guide VT Ablation With Strong Early Results

Beige Fat Shields Arteries as PRDM16 Loss Drives QSOX1 and High Blood Pressure

Vagus Nerve Repair Slows Cardiac Ageing in Preclinical Study

Low-Dose Colchicine Lowers Heart Attack and Stroke Risk in Heart Disease, Cochrane Review Finds

Celso Barros, Architect of Unimed–Fluminense Revival, Dies of Heart Attack at 73

Unpublished AHA Study Links Long-Term Melatonin Use to Higher Heart Risks

Cochrane Review Finds Low-Dose Colchicine Cuts Heart Attacks and Strokes in Heart Disease

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

AstraZeneca’s Baxdrostat Lowers 24-Hour Systolic BP by 14 mmHg in Phase 3, AHA Presentation Confirms

M. Night Shyamalan Mourns His Father, Cardiologist Nelliat C. Shyamalan, 88

Reactivated Fetal Gene Triggers Division of Adult Human Heart Cells in Lab

AstraZeneca’s Baxdrostat Hits Phase 3 Goal With 24‑Hour Blood‑Pressure Cuts

FDA Clears UCLA’s ENPP1-Blocking Antibody AD-NP1 for First-in-Human Trial